Development of novel HEPT analogs featuring significantly improved anti-resistance potency against HIV-1 through chemical space exploration of the tolerant region I

Dongwei Kang, Yanying Sun, N. Arul Murugan, Da Feng, Fenju Wei, Jing Li, Xiangyi Jiang, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Article2023

Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy

Ya-Li Sang, Christophe Pannecouque, De Clercq Erik, Shuai Wang, Fen‐Er Chen

Article2021

Discovery of Novel Dihydrothiopyrano[4,3-<i>d</i>]pyrimidine Derivatives as Potent HIV-1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles

Zhao Wang, Waleed A. Zalloum, Wenbo Wang, Xiangyi Jiang, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2024

Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile

Jiaojiao Dai, Xiangyi Jiang, Heng Gao, Boshi Huang, De Clercq Erik, Christophe Pannecouque, Shaoqing Du, Xinyong Liu, Shujing Xu